Detalhe da pesquisa
1.
Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination.
J Infect Dis
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682569
2.
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
Lancet
; 399(10323): 461-472, 2022 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065705
3.
Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination.
J Infect Dis
; 225(9): 1521-1532, 2022 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33319249
4.
Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003).
Clin Infect Dis
; 75(1): 107-117, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606595
5.
Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents.
N Engl J Med
; 381(21): 2009-2019, 2019 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31693803
6.
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia.
BMC Pulm Med
; 22(1): 447, 2022 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36437461
7.
Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America.
Clin Infect Dis
; 73(6): 1003-1012, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33822015
8.
Efficacy of a tetravalent dengue vaccine in children in Latin America.
N Engl J Med
; 372(2): 113-23, 2015 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-25365753
9.
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease.
N Engl J Med
; 373(13): 1195-206, 2015 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26214039
10.
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.
Lancet Glob Health
; 12(2): e257-e270, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38245116
11.
Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue.
Am J Trop Med Hyg
; 108(4): 722-726, 2023 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36878213
12.
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine.
medRxiv
; 2023 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523415
13.
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial.
Lancet Respir Med
; 11(11): 975-990, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37716365
14.
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.
EClinicalMedicine
; 64: 102168, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936652
15.
Prevention of influenza during mismatched seasons in older adults with an MF59-adjuvanted quadrivalent influenza vaccine: a randomised, controlled, multicentre, phase 3 efficacy study.
Lancet Infect Dis
; 21(7): 1027-1037, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33577767
16.
Zika and Dengue Interactions in the Context of a Large Dengue Vaccine Clinical Trial in Latin America.
Am J Trop Med Hyg
; 104(1): 136-144, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33169661
17.
Secondary Analysis of the Efficacy and Safety Trial Data of the Tetravalent Dengue Vaccine in Children and Adolescents in Colombia.
Pediatr Infect Dis J
; 39(4): e30-e36, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32040014
18.
Logro de las metas de colesterol LDL en pacientes con enfermedad coronaria aterosclerótica establecida / Achievement of LDL cholesterol targets in patients with coronary artery disease
Rev. colomb. cardiol
; 27(6): 511-516, nov.-dic. 2020. tab, graf
Artigo
em Espanhol
| LILACS, COLNAL | ID: biblio-1289266
19.
Prospective cohort study with active surveillance for fever in four dengue endemic countries in Latin America.
Am J Trop Med Hyg
; 93(1): 18-23, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26013373
20.
Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects.
Vaccine
; 32(39): 5027-34, 2014 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25045825